Millennium Management’s Apexigen, Inc. Common Stock APGN Stock Holding History

Millennium Management’s Portfolio APGN Stock Details APGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-21,771	Closed	-$11K	–	6959
2023 Q1	$11K	Buy	+21,771	New	+$26.2K	﹤0.01%	6016
2022 Q2	–	Sell	-14,999	Closed	-$151K	–	7733
2022 Q1	$151K	Sell	14,999 -18,170	-55%	-$182K	﹤0.01%	5965
2021 Q4	$332K	Sell	33,169 -14,720	-31%	-$147K	﹤0.01%	5437
2021 Q3	$476K	Buy	47,889 +12,500	+35%	+$124K	﹤0.01%	5401
2021 Q2	$351K	Buy	+35,389	New	+$351K	﹤0.01%	5622

Other funds holding APGN

DCMIC

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Yu Fan $97M AUM 57.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Millennium Management's APGN Position: Q2 2023 in Review

Millennium Management sold out of Apexigen, Inc. Common Stock (APGN) in Q2 2023, closing a stake of 21,771 shares — an estimated $11K sold.

Millennium Management first reported a position in APGN in Q2 2021 and held it in 5 quarters. The position peaked at $476K in Q3 2021. 17 funds tracked by Wall St. Rank hold APGN as of Q2 2023.

Millennium Management reported no remaining Apexigen, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Millennium Management sold 21,771 Apexigen, Inc. Common Stock shares in Q2 2023, an estimated $11K.
Millennium Management first reported a position in Apexigen, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
Millennium Management's Apexigen, Inc. Common Stock position peaked at $476K in Q3 2021.
17 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q2 2023.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.